Sign Up Today and Learn More About Element Biosciences Stock
Invest in or calculate the value of your shares in Element Biosciences or other pre-IPO companies through EquityZen's platform.
Element Biosciences Stock (ELEB)
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.
About Element Biosciences Stock
Founded
2017
Headquarters
San Diego, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. We are developing a modular and high-performing DNA sequencing platform that will deliver high quality data, workflow flexibility, and make next-generation sequencing technology more accessible. Our proprietary approach to improve the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation and biochemistry to drastically decrease the run cost and capital cost while delivering high sequencing data quality.
Element Biosciences Press Mentions
Stay in the know about the latest news on Element Biosciences
New Element Biosciences Workflow Speeds up Hybridization-Based Targeted Sequencing
genomeweb • Oct 23, 2024
Element Biosciences Launches Trinity™ – A Revolutionary Targeted Sequencing Innovation to Streamline Genomic Research
businesswire • Oct 16, 2024
These Female Founders And CEOs Raised The Biggest Rounds In 2024
news • Sep 13, 2024
Lucky 13: A Baker’s Dozen Join Unicorn List In July
news • Aug 13, 2024
Samsung invests in US DNA-sequencing biotech Element Biosciences
koreaherald • Aug 02, 2024
Element Biosciences Management
Leadership team at Element Biosciences
CEO
Molly He
CTO & Co-Founder
Michael Previte
Join now and verify your accreditation status to gain access to:
- Element Biosciences current valuation
- Element Biosciences stock price
- Available deals in Element Biosciences and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Element Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Element Biosciences through EquityZen funds. These investments are made available by existing Element Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Element Biosciences stock?
Shareholders can sell their Element Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."